Differential CTLs specific for prostate-specific antigen in healthy donors and patients with prostate cancer.

2.50
Hdl Handle:
http://hdl.handle.net/10541/74823
Title:
Differential CTLs specific for prostate-specific antigen in healthy donors and patients with prostate cancer.
Authors:
Elkord, Eyad; Williams, Paul E; Kynaston, Howard; Rowbottom, Anthony W
Abstract:
Induction of CTL responses specific for prostate-specific antigen (PSA)-derived peptides in healthy individuals and patients with prostate cancer (PC) was investigated. Eight PSA-derived peptides that have the potential to bind HLA-A2 molecules were examined. Peripheral blood lymphocytes isolated from HLA-A2-positive volunteers were expanded using autologous mature, PSA-derived peptide-pulsed dendritic cells. The expansion of IFN-gamma-secreting CD8+ T cells specific for three of the eight PSA-derived peptides (PSA-2(108-117), PSA-4(141-150) and PSA-6(146-154)) was detected in healthy individuals, but not in patients with PC. Using HLA-A2/peptide tetramers, the PSA-specific CD8+ T cells were detectable at low frequency both in healthy individuals and patients with PC. Using flow cytometric cytotoxicity assays, the expanded effectors from healthy individuals were able to kill the PSA-expressing epithelial cell line LNCaP and the peptide-pulsed T2 cells in a MHC class I-restricted manner without involving NK activity. However, such killing by effectors expanded from prostatectomized patients involved a complete or a significant NK activity. Specific recognition of PSA-derived peptides in healthy individuals may occur by an adaptive CTL immune response, while such recognition in PC patients may additionally or alternatively be mediated by an innate NK immune response. In conclusion, our work indicates that the PSA-specific CD8+ T cells exist in both healthy individuals and PC patients, but they have impaired function in patients as they failed to release IFN-gamma and to kill targets without involving NK activity.
Affiliation:
Department of Medical Biochemistry and Immunology, School of Medicine, Cardiff University, Cardiff, UK. eelkord@picr.man.ac.uk
Citation:
Differential CTLs specific for prostate-specific antigen in healthy donors and patients with prostate cancer. 2005, 17 (10):1315-25 Int. Immunol.
Journal:
International Immunology
Issue Date:
Oct-2005
URI:
http://hdl.handle.net/10541/74823
DOI:
10.1093/intimm/dxh309
PubMed ID:
16141246
Type:
Article
Language:
en
ISSN:
0953-8178
Appears in Collections:
All Paterson Institute for Cancer Research

Full metadata record

DC FieldValue Language
dc.contributor.authorElkord, Eyad-
dc.contributor.authorWilliams, Paul E-
dc.contributor.authorKynaston, Howard-
dc.contributor.authorRowbottom, Anthony W-
dc.date.accessioned2009-07-21T16:57:03Z-
dc.date.available2009-07-21T16:57:03Z-
dc.date.issued2005-10-
dc.identifier.citationDifferential CTLs specific for prostate-specific antigen in healthy donors and patients with prostate cancer. 2005, 17 (10):1315-25 Int. Immunol.en
dc.identifier.issn0953-8178-
dc.identifier.pmid16141246-
dc.identifier.doi10.1093/intimm/dxh309-
dc.identifier.urihttp://hdl.handle.net/10541/74823-
dc.description.abstractInduction of CTL responses specific for prostate-specific antigen (PSA)-derived peptides in healthy individuals and patients with prostate cancer (PC) was investigated. Eight PSA-derived peptides that have the potential to bind HLA-A2 molecules were examined. Peripheral blood lymphocytes isolated from HLA-A2-positive volunteers were expanded using autologous mature, PSA-derived peptide-pulsed dendritic cells. The expansion of IFN-gamma-secreting CD8+ T cells specific for three of the eight PSA-derived peptides (PSA-2(108-117), PSA-4(141-150) and PSA-6(146-154)) was detected in healthy individuals, but not in patients with PC. Using HLA-A2/peptide tetramers, the PSA-specific CD8+ T cells were detectable at low frequency both in healthy individuals and patients with PC. Using flow cytometric cytotoxicity assays, the expanded effectors from healthy individuals were able to kill the PSA-expressing epithelial cell line LNCaP and the peptide-pulsed T2 cells in a MHC class I-restricted manner without involving NK activity. However, such killing by effectors expanded from prostatectomized patients involved a complete or a significant NK activity. Specific recognition of PSA-derived peptides in healthy individuals may occur by an adaptive CTL immune response, while such recognition in PC patients may additionally or alternatively be mediated by an innate NK immune response. In conclusion, our work indicates that the PSA-specific CD8+ T cells exist in both healthy individuals and PC patients, but they have impaired function in patients as they failed to release IFN-gamma and to kill targets without involving NK activity.en
dc.language.isoenen
dc.subjectProstate Canceren
dc.subject.meshAdult-
dc.subject.meshAged-
dc.subject.meshCD8-Positive T-Lymphocytes-
dc.subject.meshCell Line-
dc.subject.meshCytotoxicity Tests, Immunologic-
dc.subject.meshFemale-
dc.subject.meshHLA-A2 Antigen-
dc.subject.meshHumans-
dc.subject.meshImmunologic Memory-
dc.subject.meshInterferon-gamma-
dc.subject.meshMale-
dc.subject.meshMiddle Aged-
dc.subject.meshPeptide Fragments-
dc.subject.meshProstate-Specific Antigen-
dc.subject.meshProstatic Neoplasms-
dc.subject.meshProtein Binding-
dc.subject.meshT-Lymphocyte Subsets-
dc.subject.meshT-Lymphocytes, Cytotoxic-
dc.titleDifferential CTLs specific for prostate-specific antigen in healthy donors and patients with prostate cancer.en
dc.typeArticleen
dc.contributor.departmentDepartment of Medical Biochemistry and Immunology, School of Medicine, Cardiff University, Cardiff, UK. eelkord@picr.man.ac.uken
dc.identifier.journalInternational Immunologyen

Related articles on PubMed

All Items in Christie are protected by copyright, with all rights reserved, unless otherwise indicated.